| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/30/1992 | US5126145 Controlled release tablet containing water soluble medicament |
| 06/30/1992 | US5126135 Dermatological composition based on an aqueous phase |
| 06/30/1992 | US5126127 Stabilized PVP-I solutions |
| 06/30/1992 | CA1304294C Pharmaceutical preparations with extended release |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |
| 06/25/1992 | WO1992010287A1 Method of producing collagen particles, and the use of such particles as substrates for active substances |
| 06/25/1992 | WO1992010212A1 Anthracycline-conjugates |
| 06/25/1992 | WO1992010211A1 Pharmaceutical formulations |
| 06/25/1992 | WO1992010171A1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
| 06/25/1992 | WO1992010169A1 Method for the manufacture of a controlled release solid unit dosage form |
| 06/25/1992 | DE4041563A1 Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren Process for the preparation of active compound-microparticle of hydrolytically degradable polymeric |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 06/24/1992 | EP0491076A1 Penetration enhancement with multi-component system of N-aliphatic pyrrolidones with lower alcohols |
| 06/24/1992 | EP0444158A4 Conjugated polypeptides and methods for their preparation and use |
| 06/24/1992 | EP0402369A4 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
| 06/23/1992 | WO1992011000A1 Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/23/1992 | US5124439 Detecting, preventing, treating blood clot formation |
| 06/23/1992 | US5124421 Addition polymers crosslinked with N,O-dimethacryloylhydroxylamine; oral drug delivery; sustained release in the duodenum |
| 06/23/1992 | US5124361 Water insoluble; forms transparent, densely structured, soft gel with good rheology and feel |
| 06/23/1992 | US5124320 An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion |
| 06/23/1992 | US5124318 Hermetic sealed container |
| 06/23/1992 | US5124317 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 06/23/1992 | US5124315 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
| 06/23/1992 | US5124158 Applying 2-pyridylmethylthio- and sulfinyl-benzimidazoles |
| 06/23/1992 | US5124155 Intraocular surgery; water swellable gel |
| 06/23/1992 | US5124154 Aminosteroids for ophthalmic use |
| 06/23/1992 | US5124152 Parenteral formulation of metolazone |
| 06/23/1992 | US5124151 Controlling ph |
| 06/23/1992 | US5124146 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/23/1992 | US5124144 Polyethylene glycol, sodium sulfate, sodium bicarbonate, sodium and potassium chlorides, saccharin, flavoring, retains isotonicity good taste |
| 06/23/1992 | US5124081 Amphiphilic lipid compounds, process for their preparation and their applications especially in cosmetics and dermopharmacy |
| 06/23/1992 | US5123414 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 06/23/1992 | CA1303993C Pharmaceutical compositions containing ranitidine |
| 06/23/1992 | CA1303992C Stable injectable solutions of vinca dimer salts |
| 06/23/1992 | CA1303990C Solubilization of hydrophobic materials using lysophospholipids |
| 06/22/1992 | WO1992011038A1 Polyamine drug-resin complexes |
| 06/22/1992 | CA2098200A1 Polyamine drug-resin complexes |
| 06/21/1992 | CA2057647A1 Transdermal delivery of dobutamine |
| 06/21/1992 | CA2032878A1 Penetration enhancement with multi-component system of n-aliphatic pyrrolidones with lower alcohols |
| 06/20/1992 | WO1992011037A2 Targeting of therapeutic agents using polysaccharides |
| 06/18/1992 | WO1992011029A1 Suppression of immune responses with oligomeric forms of antigen of controlled chemistry |
| 06/18/1992 | CA2098281A1 Suppression of immune responses of oligomeric forms of antigen of controlled chemistry |
| 06/18/1992 | CA2032385A1 Enzymatically debranched starches as tablet excipients |
| 06/17/1992 | EP0490806A2 Nasal pharmaceutical compositions |
| 06/17/1992 | EP0490648A1 Pharmaceutical agents |
| 06/17/1992 | EP0490549A1 Stabilisation of pharmaceutical compositions comprising calcitonin |
| 06/17/1992 | EP0490434A1 Labelled, modified oligonucleotides |
| 06/17/1992 | EP0490305A2 Microspheres for ophthalmic use |
| 06/17/1992 | EP0490193A1 Complex of an actif enantiomer of ibuprofen with cyclodextrin |
| 06/17/1992 | EP0490077A1 Antisense oligonucleotides for treatment of cancer |
| 06/17/1992 | EP0490038A1 Use of high cleaned vesicular material as additive to food and in cosmetic preparations |
| 06/17/1992 | EP0489931A1 Immunotoxin complex |
| 06/17/1992 | EP0489898A1 Self-emulsifying glasses |
| 06/17/1992 | EP0489843A1 Bioerodible polymers useful for the controlled release of therapeutic agents |
| 06/17/1992 | EP0357637B1 General cancer-associated scm-recognition factor, preparation and method of use |
| 06/17/1992 | EP0257063B1 Compositions comprising 1-substituted azacycloalkanes and their uses |
| 06/17/1992 | EP0185680B1 Steroidal liposomes |
| 06/17/1992 | DE4039602A1 Pharmazeutische formulierungen Pharmaceutical formulations |
| 06/17/1992 | CN1061907A Suspendible composition and process for prepairng same |
| 06/17/1992 | CN1061905A 硬胶囊制剂 Hard capsule preparation |
| 06/16/1992 | US5122614 Stable, hydrolysis resistant linkages |
| 06/16/1992 | US5122598 Total and partial esterification of cellulose, starch and chitin groups with alcohols; inorganic and organic based salts of partial esters; therapeutic substances; creams, sprays, solutions |
| 06/16/1992 | US5122543 Syrup of carbamazepine in protective polymeric colloid |
| 06/16/1992 | US5122540 Method and composition for treating warts and throat soreness with DMSO and citric acid |
| 06/16/1992 | US5122520 Amidated by a 3a,7a,12a-trihydroxy cholestanecarboxylic acid; transmucuous resorption ptomoter of drugs; inhalants |
| 06/16/1992 | US5122519 Tetracyclines in solvent, gelling vehicle |
| 06/16/1992 | US5122383 For administering steroid drugs through skin |
| 06/16/1992 | US5122382 Transdermal contraceptive formulations, methods and devices |
| 06/16/1992 | US5122381 Antifading agents for colored drinks; quercetin-3-O-glycosides |
| 06/16/1992 | US5122376 Calcitonin gene related peptide |
| 06/16/1992 | US5122370 Method for treating acne vulgaris with a composition containing a stable, high purity, substantially anhydrous complex of PVP-H2 O.sub.2 |
| 06/16/1992 | US5122368 Anthracycline conjugates having a novel linker and methods for their production |
| 06/16/1992 | US5122367 Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone |
| 06/16/1992 | US5122301 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 06/16/1992 | CA1303524C Drug-monoclonal antibody conjugates |
| 06/16/1992 | CA1303510C Stable aqueous solution of vincristine sulfate |
| 06/16/1992 | CA1303504C Pharmaceutical formulation containing acrivastine |
| 06/16/1992 | CA1303503C Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex |
| 06/16/1992 | CA1303502C Sustained release pharmaceutical compositions in oral dosage form |
| 06/16/1992 | CA1303499C Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| 06/16/1992 | CA1303415C Confectionery of pharmaceutical product with a sugarless coating obtained by hard coating and method for its preparation |
| 06/15/1992 | CA2056835A1 Hydrophilic form of perfluoro compounds and methods of manufacture |
| 06/13/1992 | WO1992010168A1 Directly compressible xylitol and method |
| 06/13/1992 | CA2055522A1 Microspheres for ophthalmic use |
| 06/12/1992 | WO1992010166A1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
| 06/11/1992 | WO1992010154A1 Method and systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers |
| 06/11/1992 | WO1992009690A2 Enrichment method for variant proteins with altered binding properties |
| 06/11/1992 | WO1992009636A1 Skin protective compositions and method of inhibiting skin irritation |
| 06/11/1992 | WO1992009308A1 Complexes of the active enantiomer of ibuprofene with cyclodextrin |
| 06/11/1992 | WO1992009307A1 A gel-forming liquid carrier composition |
| 06/11/1992 | WO1992009272A1 Method and composition for controlled delivery of biologically active agents |
| 06/11/1992 | WO1992009271A1 Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof |
| 06/11/1992 | WO1992009267A1 Methods of immobilizing liposomes in gel beads and similar materials, gel beads and similar materials with immobilized liposomes prepared by such methods and uses thereof |
| 06/11/1992 | WO1992009266A1 Topical composition |
| 06/11/1992 | CA2405246A1 Enrichment method for variant proteins with alterred binding properties |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/10/1992 | EP0489220A1 Cytotoxic N,N'-bis (succinyl-peptide-) derivatives of 1,4-bis (aminoalkyl)-5,8-dihydroxyanthraquinones and antibody conjugates thereof |
| 06/10/1992 | EP0489217A1 Calcitonin compositions for intranasal administration |